We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$87.8M
AUM Growth
-$35.8M
Cap. Flow
-$37.4M
Cap. Flow %
-42.62%
Top 10 Hldgs %
58.31%
Holding
59
New
–
Increased
–
Reduced
40
Closed
12
Avg Time Held
14.8 quarters
Top 10 Avg Time Held
3.3 quarters
Top 20 Avg Time Held
8.6 quarters

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IDTI
Integrated Device Technology I
IDTI
+$5.42M
2
CLDR
Cloudera, Inc.
CLDR
+$4.32M
3
TWLO icon
Twilio
TWLO
+$2.22M
4
NEO icon
NeoGenomics
NEO
+$1.51M
5
CYBR icon
CyberArk
CYBR
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 46%
2 Technology 39.72%
3 Miscellaneous 3.85%
4 Financials 2.7%
5 Consumer Discretionary 2.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NEO icon
1
NeoGenomics
NEO
$2.09B
$7.18M 8.18%
327,438
-68,889
-17% -$1.51M
2013 Q2
24 quarters
TWLO icon
2
Twilio
TWLO
$43.9B
$6.69M 7.62%
49,044
-16,635
-25% -$2.22M
2017 Q4
6 quarters
VCEL icon
3
Vericel Corp
VCEL
$2.07B
$5.99M 6.82%
317,079
-73,995
-19% -$1.26M
2017 Q1
9 quarters
CY
4
DELISTED
Cypress Semiconductor
CY
$5.53M 6.3%
248,494
-67,312
-21% -$1.22M
2018 Q1
5 quarters
UPLD icon
5
Upland Software
UPLD
$10.7M
$5.04M 5.74%
11,061
-2,745
-20% -$1.26M
2018 Q4
2 quarters
CYBR icon
6
DELISTED
CyberArk
CYBR
$4.78M 5.44%
37,383
-10,161
-21% -$1.29M
2016 Q4
10 quarters
OMCL icon
7
Omnicell
OMCL
$1.63B
$4.17M 4.75%
48,428
-12,638
-21% -$1.03M
2013 Q2
24 quarters
ATRC icon
8
AtriCure
ATRC
$2.83B
$4.02M 4.58%
134,696
-37,273
-22% -$1.09M
2013 Q2
24 quarters
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.9M 4.44%
162,142
-40,385
-20% -$1.02M
2017 Q2
8 quarters
PODD icon
10
Insulet
PODD
$9.42B
$3.9M 4.44%
32,629
-3,956
-11% -$406K
2014 Q2
20 quarters
FIVN icon
11
FIVE9
FIVN
$2.71B
$3.62M 4.13%
70,614
-18,212
-21% -$924K
2018 Q4
2 quarters
MXL icon
12
MaxLinear
MXL
$8.39B
$3.4M 3.88%
145,212
-36,544
-20% -$890K
2014 Q3
19 quarters
SRGA
13
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.07M 3.5%
24,080
-5,510
-19% -$793K
2013 Q2
24 quarters
XENT
14
DELISTED
Intersect ENT, Inc
XENT
$3.02M 3.45%
132,924
-28,184
-17% -$760K
2015 Q1
17 quarters
SUPN icon
15
Supernus Pharmaceuticals
SUPN
$2.48B
$2.56M 2.92%
77,392
-22,583
-23% -$774K
2016 Q2
12 quarters
FNSR
16
DELISTED
Finisar Corp
FNSR
$2.36M 2.69%
103,348
-31,957
-24% -$732K
2013 Q2
24 quarters
CVLT icon
17
Commault Systems
CVLT
$6.56B
$2.09M 2.38%
42,180
-13,248
-24% -$704K
2014 Q2
20 quarters
LGND icon
18
Ligand Pharmaceuticals
LGND
$6.02B
$1.63M 1.85%
22,864
-7,899
-26% -$582K
2013 Q2
24 quarters
SPY icon
19
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$1.3M 1.49%
4,450
– –
2013 Q2
24 quarters
AAPL icon
20
Apple
AAPL
$4.97T
$889K 1.01%
17,976
-11,368
-39% -$554K
2016 Q3
11 quarters
MAR icon
21
Marriott International
MAR
$95.4B
$740K 0.84%
5,276
-3,218
-38% -$427K
2013 Q2
24 quarters
AFL icon
22
Aflac
AFL
$57.8B
$701K 0.8%
12,798
-7,529
-37% -$388K
2013 Q2
24 quarters
PG icon
23
Procter & Gamble
PG
$352B
$643K 0.73%
5,866
-3,576
-38% -$381K
2013 Q2
24 quarters
QQQ icon
24
Invesco QQQ Trust
QQQ
$500B
$640K 0.73%
3,425
– –
2013 Q3
23 quarters
JPM icon
25
JPMorgan Chase
JPM
$888B
$612K 0.7%
5,477
-3,450
-39% -$380K
2016 Q3
11 quarters
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Kopp Investment Advisors held 59 positions worth $87.8M, down 29% from $124M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Kopp Investment Advisors withdrew a net $37.4M in Q2 2019, closing 12 positions and reducing 40 holdings. Its most notable exit was Integrated Device Technology I, an estimated $5.42M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Technology and Miscellaneous.

  • Kopp Investment Advisors's biggest Q2 2019 reduction was Twilio, cutting an estimated $2.22M.
  • Kopp Investment Advisors fully exited Integrated Device Technology I in Q2 2019, selling an estimated $5.42M.
  • Kopp Investment Advisors's ten largest holdings make up 58% of its $87.8M portfolio in Q2 2019.
  • Kopp Investment Advisors opened 0 new positions and closed 12 in Q2 2019.
  • Kopp Investment Advisors's portfolio value fell 29% quarter-over-quarter to $87.8M.

Based on Kopp Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.